Stay updated on Safety of SNA-120 in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.

Latest updates to the Safety of SNA-120 in Psoriasis Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision indicator changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error with basic site chrome, indicating access to the study record is blocked.SummaryDifference19%

- Check56 days agoChange DetectedThe site revision was updated from v3.6.5 to v3.6.6, indicating an underlying platform update. No study data or page content appear to be modified.SummaryDifference0.0%

- Check77 days agoChange DetectedAn error-page HTML block was added, indicating the requested page is currently unavailable due to an error (nginx message).SummaryDifference18%

- Check91 days agoChange DetectedThe page's revision number was updated from v3.6.3 to v3.6.4, indicating a small update to the page metadata rather than substantive content.SummaryDifference0.0%

Stay in the know with updates to Safety of SNA-120 in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.